Methylene blue post-treatment improves hypoxia-ischemic recovery in a neonatal rat model

Keyphrases

• Methylene Blue 100%
• Hypoxia-ischemia 100%
• Neonatal Rat Model 100%
• Cortex 27%
• Hippocampus 27%
• Mitochondrial Function 18%
• Blood-brain Barrier Disruption 18%
• Neonatal Hypoxic-ischemic Encephalopathy 18%
• Oxidative Stress 9%
• Neurological Disorders 9%
• Attenuation 9%
• Oxidative Damage 9%
• Neuronal Damage 9%
• Neonatal Hypoxic-ischemic Brain Injury 9%
• Neuroprotective Action 9%
• Beneficial Effects 9%
• Mitochondrial Fragmentation 9%
• Neuronal Death 9%
• Spatial Reference Memory 9%
• Neuroinflammation 9%
• Behavioral Tests 9%
• Protein Carbonyls 9%
• Neonatal Rats 9%
• Astrocyte Activation 9%
• Microglial Activation 9%
• Mechanistic Analysis 9%
• Hypoxic-ischemic Insult 9%
• Motor Coordination 9%
• Brain Damage 9%
• Inflammatory Cytokine Expression 9%
• Hypoxic-ischemic Brain 9%

Pharmacology, Toxicology and Pharmaceutical Science

• Rat Model 100%
• Hypoxia 100%
• Carbene 100%
• Hypoxic Ischemic Encephalopathy 18%
• Blood-Brain Barrier 18%
• Rat 18%
• Cytokine 9%
• Neuroprotective Agent 9%
• Nervous System Inflammation 9%

Neuroscience

• Methylene Blue 100%
• Hippocampus 27%
• Blood Brain Barrier 18%
• Mitochondrial Function 18%
• Hypoxic Ischemic Encephalopathy 18%
• Oxidative Stress 9%
• Astrocyte 9%
• Neuronal Cell Death 9%
• Microglia 9%
• Neuroprotective Agent 9%
• Proinflammatory Cytokine 9%
• Reference Memory 9%
• Cytokine Production 9%
• Behavioral Test 9%
• Nervous System Disorder 9%
• Motor Coordination 9%